Conditions: Fibromyalgia
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 106
Healthy volunteers: no

Brief summary:
This study will assess the safety and efficacy of the long-term use of pregabalin at doses up to 450 mg/day in patients with fibromyalgia who have completed 16 weeks of dosing in Study A0081208 (NCT00830167).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: pregabalin (Lyrica)
Intervention descriptions: intervention 1: Dosage: 300-450 mg/day (150-225 mg twice daily), oral administration, Treatment duration: 52 weeks

Protocol document: